Measuring Emotional Awareness in Patients With Schizophrenia and Schizoaffective Disorders

被引:3
|
作者
Maassen, Eva [1 ,2 ,3 ]
Buettner, Marielle [1 ,2 ,3 ]
Broecker, Anna-Lena [1 ,2 ,3 ]
Stuke, Frauke [1 ,2 ,3 ]
Bayer, Samuel [1 ,2 ,3 ,4 ]
Hadzibegovic, Jasmina [1 ,2 ,3 ]
Just, Sandra Anna [1 ,2 ,3 ]
Bertram, Gianna [1 ,2 ,3 ]
Rau, Richard [5 ]
von Haebler, Dorothea [1 ,2 ,3 ,4 ]
Lempa, Guenter [6 ]
Montag, Christiane [1 ,2 ,3 ]
机构
[1] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Psychiat Univ Clin, St Hedwig Hosp, Berlin, Germany
[2] Humboldt Univ, Freie Univ Berlin, Berlin, Germany
[3] Berlin Inst Hlth, Berlin, Germany
[4] Psychoanalyt Univ Berlin, Berlin, Germany
[5] Univ Munster, Dept Psychol, Munster, Germany
[6] Psychotherapy Practice, Munich, Germany
来源
FRONTIERS IN PSYCHOLOGY | 2021年 / 12卷
关键词
schizophrenia; emotional awareness; affective mentalizing; theory of mind; levels of emotional awareness scale; METACOGNITION ASSESSMENT SCALE; NEGATIVE-SYNDROME-SCALE; SOCIAL COGNITION; MIND; ASSOCIATIONS; DEFICITS; RECOGNITION; ALEXITHYMIA; EMPATHY; SELF;
D O I
10.3389/fpsyg.2021.725787
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
The ability to mentalize (i.e., to form representations of mental states and processes of oneself and others) is often impaired in people with schizophrenia spectrum disorders. Emotional awareness (EA) represents one aspect of affective mentalizing and can be assessed with the Levels of Emotional Awareness Scale (LEAS), but findings regarding individuals with schizophrenia spectrum disorders are inconsistent. The present study aimed at examining the usability and convergent validity of the LEAS in a sample of N = 130 stabilized outpatients with schizophrenia or schizoaffective disorders. An adequacy rating was added to the conventional LEAS rating to account for distortions of content due to, for example, delusional thinking. Scores of the patient group were compared with those of a matched healthy control sample. Correlation with symptom clusters, a self-report measure of EA, a measure of synthetic metacognition (MAS-A-G), and an expert rating capturing EA from the psychodynamic perspective of psychic structure (OPD-LSIA) were examined. Regarding self-related emotional awareness, patients did not score lower than controls neither in terms of conventional LEAS nor in terms of adequacy. Regarding other-related emotional awareness, however, patients showed a reduced level of adequacy compared to controls whereas no such difference was found for conventional LEAS scores. Higher conventional LEAS scores were associated with fewer negative symptoms, and higher structural integration of self-perceptions measured by the OPD-LSIA. Higher adequacy of responses correlated with fewer symptoms of disorganization as well as excitement, higher scores of self-reflection on the MAS-A-G as well as self- and object-perception and internal and external communication as measured by the subscales of the OPD-LSIA. Findings suggest that the LEAS might not be sensitive enough to detect differences between mildly symptomatic patients with schizophrenia or schizoaffective disorders and healthy controls. However, LEAS ratings are still suitable to track intraindividual changes in EA over time. Observing the adequacy of patients' responses when using the LEAS may be a promising way to increase diagnostical utility and to identify patterns of formal and content-related alterations of mentalizing in this patient group. Methodological indications for future studies are discussed.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Criteria for symptom remission revisited: a study of patients affected by schizophrenia and schizoaffective disorders
    Pinna, Federica
    Tusconi, Massimo
    Bosia, Marta
    Cavallaro, Roberto
    Carpiniello, Bernardo
    [J]. BMC PSYCHIATRY, 2013, 13
  • [22] Effect of emotional awareness skills training on emotional awareness and communication skills in patients with schizophrenia: A Randomized Controlled Trial
    Uzun, Gulten
    Lok, Neslihan
    [J]. ARCHIVES OF PSYCHIATRIC NURSING, 2022, 38 : 14 - 20
  • [23] Relative Perceptions of the Needs of Inpatients with Schizophrenia and Schizoaffective Disorders
    Grinshpoon, Alexander
    Friger, Michael
    Orev, Eyal
    Shvarts, Shifra
    Kaplan, Ze'ev
    Abramowitz, Moshe Z.
    Ponizovsky, Alexander M.
    [J]. ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2008, 45 (03): : 201 - 209
  • [24] Assessment of basic symptoms in schizophrenia, schizoaffective and bipolar disorders
    Ricca, V
    Galassi, F
    LaMalfa, G
    Mannucci, E
    Barciulli, E
    Cabras, PL
    [J]. PSYCHOPATHOLOGY, 1997, 30 (01) : 53 - 58
  • [25] Neurocognition in Early-Onset Schizophrenia and Schizoaffective Disorders
    Hooper, Stephen R.
    Giuliano, Anthony J.
    Youngstrom, Eric A.
    Breiger, David
    Sikich, Linmarie
    Frazier, Jean A.
    Findling, Robert L.
    McClellan, Jon
    Hamer, Robert M.
    Vitiello, Benedetto
    Lieberman, Jeffrey A.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2010, 49 (01): : 52 - 60
  • [26] FACTORS RELATED TO EMPLOYABILITY OF OUTPATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDERS
    Martini, Larissa C.
    Petreche, Beatriz
    Lima, Fernanda Vieira
    Barbosa, Patricia
    Silva, Ana Olivia
    Moraes, Gisela
    Ferreira, Carlos Antonio
    Attux, Cecilia
    Bressan, Rodrigo
    [J]. SCHIZOPHRENIA RESEARCH, 2014, 153 : S345 - S345
  • [27] Electrocardiographic abnormalities and psychotropic polypharmacy in schizophrenia and schizoaffective disorders
    Tirupati, Srinivasan
    Gulati, Sachal
    [J]. AUSTRALASIAN PSYCHIATRY, 2022, 30 (02) : 243 - 246
  • [28] Effect of therapy with atypical antipsychotic drugs on prolactin concentration in patients with schizophrenia and schizoaffective disorders
    L. N. Gorobets
    [J]. Bulletin of Experimental Biology and Medicine, 2005, 140 : 714 - 715
  • [29] Therapy of strong agitated patients with Olanzapine: a study of 166 patients with schizophrenia, schizoaffective disorders and bipolar-I-disorders
    Huber, Christian G.
    Lambert, M.
    Naber, D.
    Schacht, A.
    Wagner, T.
    Hundemer, H. -P.
    Karow, A.
    Schimmelmann, B.
    [J]. NERVENARZT, 2007, 78 : 88 - 88
  • [30] Maintenance medication for schizophrenia and schizoaffective patients
    Lerner, V
    Fotyanov, M
    Liberman, M
    Shlafman, M
    BarEl, Y
    [J]. SCHIZOPHRENIA BULLETIN, 1995, 21 (04) : 693 - 701